GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,054 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +27 vs. previous quarter
- 1,054
- 13F valueReported value at the end of Q2 2026
- $18.2B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in GBP.
- Revenue, FY2025
- GBP 32.7B
- +4.1% year over year
- Net income, FY2025
- GBP 6.29B
- +113.1% year over year
- Free cash flow, FY2025
- GBP 6.39B
- +24.0% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 16.1M
- Shares sold short
- Change
- +1.57M
- +10.8% vs. previous
- Days to cover
- 3.18
- At average daily volume
Superinvestors holding GSK, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GSK at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by GSK plc insiders from Form 4, newest first.
No open-market purchases or sales by GSK plc insiders are on file.
Top 10 13F holders, Q2 2026
See all 1,054 holdersThe largest institutional positions in GSK plc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 64,961,641 | $3.41B | 0.15% | −2,700,005−4.0% | Reduced |
| Dodge & Cox | 48,197,514 | $2.53B | 1.32% | −10,465,460−17.8% | Reduced |
| Fisher Asset Management, LLC | 35,722,792 | $1.87B | 0.56% | +1,200,429+3.5% | Added |
| Primecap Management Co | 25,182,068 | $1.32B | 0.78% | −22,470−0.1% | Reduced |
| Wellington Management Group LLP | 11,396,249 | $597.4M | 0.10% | −321,364−2.7% | Reduced |
| JTC Employer Solutions Trusteee Ltd | 8,592,987 | $450.3M | 36.13% | −449,402−5.0% | Reduced |
| Morgan Stanley | 7,657,562 | $401.4M | 0.02% | −3,373,089−30.6% | Reduced |
| Royal Bank of Canada | 7,588,928 | $397.8M | 0.07% | +82,142+1.1% | Added |
| Price T Rowe Associates Inc | 6,923,642 | $362.9M | 0.04% | −399,191−5.5% | Reduced |
| Acadian Asset Management LLC | 6,660,434 | $349.1M | 0.41% | −5,136,651−43.5% | Reduced |
Politician trades
All politician trades in GSK12 members of Congress reported 45 trades in GSK plc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 | Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Oct 10, 2025 | Val T. Hoyle House · OR | Sell | $1K-$15K |

Senate · OK · Jul 21, 2026
Buy$15K-$50K

House · MI · Nov 21, 2025
Sell$1K-$15K

House · MI · Nov 21, 2025
Buy$1K-$15K

House · MI · Nov 21, 2025
Sell$1K-$15K

House · OR · Oct 10, 2025
Sell$1K-$15K